UnknownPhase 3NCT03413306

Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Principal Investigator
Galina Novichkova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology
Intervention
Eltrombopag(drug)
Enrollment
100 enrolled
Eligibility
2-18 years · All sexes
Timeline
20162022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03413306 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials